[原创]活体动物生物发光成像技术在肿瘤学研究中的文献列表

In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells
Qian D.Z., Ren M., Wei Y., Wang X., van de Geijn F., Rasmussen C., Nakanishi O., Sacchi N., and Pili R. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD 21231, USA.
Prostate, June 15 2005, Vol. 64, pp. 20-28.

Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis
Notting I.C., Buijs J.T., Que I., Mintardjo R.E., Van Der Horst G., Karperien M., Missotten G.S., Jager M.J., Schalij-Delfos N.E., Keunen J.E., and Van Der Pluijm G. Dept. of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
Investigative Ophthalmology and Visual Science, May 2005, Vol. 46, pp. 1581-1587.

Bone turnover mediates preferential localization of prostate cancer in the skeleton
Schneider A., Kalikin L.M., Mattos A.C., Keller E.T., Allen M.J., Pienta K.J., and McCauley L.K., Dept. of Periodontics/Prevention/Geriatrics, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.
Endocrinology, Apr. 2005, Vol. 146, pp. 1727-1736.

Unraveling the complexity of oncogenesis through in vivo optical imaging
Contag P.R.
Cancer Drug Discovery and Development: the Oncogenomics Handbook. Edited by LaRochelle W.J., and Shimkets R.A. Humana Press, Inc. Totowa, NJ, Chapter 17, pp. 263-274, Apr. 2005.

Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models
Nogawa M., Yuasa T., Kimura S., Kuroda J., Sato K., Segawa H., Yokota A., and Maekawa T. Dept. of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto 606-8507, Japan.
Cancer Letters, Jan. 2005, Vol. 217, pp. 243-253.

A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo
Yuasa T., Nogawa M., Kimura S., Yokota A., Sato K., Segawa H., Kuroda J., and Maekawa T. Dept. of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Clinical Cancer Research, Jan. 2005, Vol. 11, pp. 853-859.

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., Doubrovin M., Ponomarev V., Gerald W.L., Blasberg R., and Massague J. Cancer Biology and Genetics Program, Dept. of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Journal of Clinical Investigation, Jan. 2005, Vol. 115, pp. 44-55.

Advances in imaging mouse tumour models in vivo
Lyons S.K.
Oncology Dept., Xenogen Corp., Alameda, CA 94501, USA.
Journal of Pathology, Jan. 2005, Vol. 205, pp. 194-205.

Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus
Kanerva A., Zinn K.R., Peng K.W., Ranki T., Kangasniemi L., Chaudhuri T.R., Desmond, R.A., Wang M., Takayama K., Hakkarainen T., Alfthan H., Stenman U.H., Curiel D.T., and Hemminki A. Cancer Gene Therapy Group, Rational Drug Design, Biomedicum Helsinki, University of Helsinki, Finland.
Gene Therapy, Jan. 2005, Vol. 12, pp. 87-94.

Spying on cancer: Molecular imaging in vivo with genetically encoded reporters
Gross S., and Piwnica-Worms D. Molecular Imaging Center, Mallinckrodt Institute of Radiology, Dept. of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, MO 63110, USA.
Cancer Cell, Jan. 2005, Vol. 7, pp. 5-15.

CXCR4 regulates growth of both primary and metastatic breast cancer
Smith M.C., Luker K.E., Garbow J.R., Prior J.L., Jackson E., Piwnica-Worms D., and Luker G.D. Molecular Imaging Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cancer Research, Dec. 2004, Vol. 64, pp. 8604-8612.

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Fei P., Wang W., Kim S.H., Wang S., Burns T.F., Sax J.K., Buzzai M., Dicker D.T., McKenna W.G., Bernhard E.J., and El-Deiry W.S. University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Cancer Cell, Dec. 2004, Vol. 6, pp. 597-609.

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
Douma S., Van Laar T., Zevenhoven J., Meuwissen R., Van Garderen E., and Peeper D.S. Div. of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
Nature, August 2004, Vol. 430, pp. 1034-1039.

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts
Chen X., Conti P.S., and Moats R.A. PET Imaging Science Center, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.
Cancer Research, Nov. 2004, Vol. 64, pp. 8009-8014.

Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model
Uhrbom L., Nerio E., and Holland E.C. Uppsala University, Dept. of Genetics and Pathology, Rudbeck Laboratory, Uppsala SE-75185, Sweden.
Nature Medicine, Nov. 2004, Vol. 10, pp. 1257-1260.

Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy
Mocanu J.D., Moriyama E.H., Chia M.C., Li J.H., Yip K.W., Huang D.P., Bastianutto C., Wilson B.C., and Liu F.F. University of Toronto, Princess Margaret Hospital/Ontario Cancer Institute, 610 University Avenue, Toronto, ONT M5G 2M9, Canada.
Molecular Imaging, Oct. 2004, Vol. 3, pp. 352-355.

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., Yang Q., Bishop J.M., Contag C.H., and Felsher D.W. Div. of Medical Oncology, Dept. of Medicine, Stanford University, Stanford, CA 94305, USA.
Nature, Oct. 2004, Vol. 431, pp. 1112-1117.

Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy
Moriyama E.H., Bisland S.K., Lilge L., and Wilson B.C. Dept. of Medical Biophysics, Ontario Cancer Institute, University of Toronto, Toronto, ONT M5G 2M9, Canada.
Photochemistry and Photobiology, Sep.-Oct. 2004, Vol. 80, pp. 242-249.

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
Walensky L.D., Kung A.L., Escher I., Malia T.J., Barbuto S., Wright R.D., Wagner G., Verdine G.L., and Korsmeyer S.J. Howard Hughes Medical Institute, Dept. of Pediatric Hematology/Oncology and Children's Hospital Boston, MA 02115, USA.
Science, Sep. 2004, Vol. 305, pp. 1466-1470.

Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor
Blankenberg F.G., Mandl S., Cao Y.A., O'Connell-Rodwell C., Contag C., Mari C., Gaynutdinov T.I., Vanderheyden J.L., Backer M.V., and Backer J.M. Dept. of Pediatrics, Stanford University, Stanford, CA 94304, USA.
The Journal of Nuclear Medicine, August 2004, Vol. 45, pp. 1373-1380.

Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice
Sarraf-Yazdi S., Mi J., Dewhirst M.W., and Clary B.M. Dept. of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Journal of Surgical Research, Aug. 2004, Vol. 120, pp. 249-255.

Overriding imatinib resistance with a novel ABL kinase inhibitor
Shah N.P., Tran C., Lee F.Y., Chen P., Norris D., and Sawyers C.L., Div. of Hematology and Oncology, Dept. of Medicine, The David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Science, July 2004, Vol. 305, pp. 399-401.

Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
Kung A.L., Zabludoff S.D., France D.S., Freedman S.J., Tanner E.A., Vieira A., Cornell-Kennon S., Lee J., Wang B., Wang J., Memmert K., Naegeli H.U., Petersen F., Eck M.J., Bair K.W., Wood A.W., and Livingston D.M. Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
Cancer Cell, July 2004, Vol. 6, pp. 33-43.

In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer
Zhang J., Lu Y., Dai J., Yao Z., Kitazawa R., Kitazawa S., Zhao X., Hall D.E., Pienta K.J., and Keller E.T. Dept. of Pathology and Unit for Laboratory Animal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Prostate, June 2004, Vol. 59, pp. 360-369.

Imaging of bioluminescent LNCaP-luc-M6 tumors: A new animal model for the study of metastatic human prostate cancer
Scatena C.D., Hepner, M.A., Oei Y.A., Dusich J.M., Yu S.F., Purchio T., Contag P.R., and Jenkins D.E. Xenogen Corp., Alameda, CA 94501, USA.
Prostate, May 2004, Vol. 59, pp. 292-303.

Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22
Qiu Z., Harms J.S., Zhu J., and Splitter G.A. Dept. of Animal Health and Biomedical Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Journal of Virology, Apr. 2004, Vol. 78, pp. 4224-4233.

A potential role for imaging technology in anticancer efficacy evaluations
Hollingshead M.G., Bonomi C.A., Borgel S.D., Carter J.P., Shoemaker R., Melillo G., and Sausville E.A. Developmental Therapeutics Program, Div. of Cancer Diagnosis and Treatment, National Cancer Institute, Bethesda, MD 20892, USA.
European Journal of Cancer, April 2004, Vol. 40, pp. 890-898.

In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats
Zeamari S., Rumping G., Floot B., Lyons S., and Stewart F.A. Div.s of Experimental Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam 1066 CX, The Netherlands.
British Journal of Cancer, Mar. 2004, Vol. 90, pp. 1259-1264.

The EZC-prostate model: Noninvasive prostate imaging in living mice
Xie X., Luo Z., Slawin K.M., and Spencer D.M. Dept. of Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Molecular Endocrinology, Mar. 2004, Vol. 18, pp. 722-732.

Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice
Verra N.C., Jorritsma A., Weijer K., Ruizendaal J.J., Voordouw A., Weder P., Hooijberg E., Schumacher T.N., Haanen J.B., Spits H., and Luiten R.M. Div. of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Cancer Research, Mar. 2004, Vol. 64, pp. 2153-2161.

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
Mitsiades C.S., Mitsiades N.S., McMullan C.J., Poulaki V., Shringarpure R., Akiyama M., Hideshima T., Chauhan D., Joseph M., Libermann T.A., Garcia-Echeverria C., Pearson M.A., Hofmann F., Anderson K.C., and Kung A.L. Dept. of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Cancer Cell, Mar. 2004, Vol. 5, pp. 221-230.

Systemic tumor targeting and killing by sindbis viral vectors
Tseng, J.C., Levin, B., Hurtado, A., Yee, H., Perez de Castro, I., Jimenez, M., Shamamian, P., Jin R., Novick R.P., Pellicer A., and Meruelo D. New York University Gene Therapy Center, NYU Cancer Institute, NYU School of Medicine, New York, NY 10016, USA.
Nature Biotechnology, Jan. 2004, Vol. 22, pp. 70-77.

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy
Wang S., and El-Deiry W.S. Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Dept. of Medicine, and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Proceedings of the National Academy of Sciences of the United States of America, December 2003, Vol. 100, pp. 15095-15100.

The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice
Lyons, S.K., Meuwissen, R., Krimpenfort, P., and Berns, A. Div. of Molecular Genetics and Centre of Biomedical Genetics, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Cancer Research, Nov. 2003, Vol. 63, pp. 7042-7046.

Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells
Collisson E.A., Kleer C., Wu M., De A., Gambhir S.S., Merajver S.D., and Kolodney M.S. Dept. of Medicine, Div. of Dermatology, Harbor-UCLA, Torrance, CA 90509, USA.
Molecular Cancer Therapy, Oct. 2003, Vol. 2, pp. 941-948.

Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research
Choy G., Choyke P., and Libutti S.K. National Cancer Institute, Bethesda, MD 20892, USA.
Molecular Imaging, Oct. 2003, Vol. 2, pp. 303-312.

Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
Abrams T.J., Murray L.J., Pesenti E., Holway V.W., Colombo T., Lee L.B., Cherrington J.M., and Pryer N.K. Preclinical Research and Experimental Development, SUGEN, Inc., South San Francisco, CA 94080, USA.
Molecular Cancer Therapy, Oct. 2003, Vol. 2, pp. 1011-1021.

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
Kanerva, A., Zinn, K.R., Chaudhuri, T.R., Lam, J.T., Suzuki, K., Uil, T.G., Hakkarainen, T., Bauerschmitz, G.J., Wang, M., Liu, B., Cao, Z., Alvarez, R.D., Curiel, D.T., and Hemminki, A. Div. of Human Gene Therapy, Dept. of Medicine, Dept. of Pathology, and Dept. of Surgery, Finland.
Molecular Therapy, Sep. 2003, Vol. 8, pp. 449-458.

Interrogating androgen receptor function in recurrent prostate cancer
Zhang L., Johnson M., Le K.H., Sato M., Ilagan R., Iyer M., Gambhir S.S., Wu L., and Carey M. Dept.s of Biological Chemistry, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA.
Cancer Research, August 2003, Vol. 63, pp. 4552-4560.

Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice
Burgos J.S., Rosol M., Moats R.A., Khankaldyyan V., Kohn D.B., Nelson M.D., Jr., and Laug W.E. Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Biotechniques, June 2003, Vol. 34, pp. 1184-1188.

Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model
Wang W., and El-Deiry W.S. Howard Hughes Medical Institute, Dept. of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Cancer Biology & Therapy, Mar.-Apr. 2003, Vol. 2, pp. 196-202.

Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice
Ray P., Wu A.M., and Gambhir S.S. Crump Institute for Molecular Imaging, Dept. of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Cancer Research, Mar. 2003, Vol. 63, pp. 1160-1165.

Animal models of bone metastasis
Rosol T.J., Tannehill-Gregg S.H., LeRoy B.E., Mandl S., and Contag C.H. Dept. of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA.
Cancer, Feb. 2003, Vol. 97, pp. 748-757.

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model
Murray, L.J., Abrams, T.J., Long, K.R., Ngai, T.J., Olson, L.M., Hong, W., Keast, P.K., Brassard, J.A., O'Farrell, A.M., Cherrington, J.M., and Pryer, N.K. SUGEN, Inc. South San Francisco, CA 94080, USA.
Clinical and Experimental Metastasis, Jan. 2003, Vol. 20, pp. 757-766.

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship
Mendel D.B., Laird A.D., Xin X., Louie S.G., Christensen J.G., Li, G., Schreck R.E., Abrams T.J., Ngai T.J., Lee L.B., Murray L.J., Carver J., Chan E., Moss K.G., Haznedar J.O., Sukbuntherng J., Blake R.A., Sun L., Tang C., Miller T., Shirazian S., McMahon G., and Cherrington J.M. Preclinical Research and Exploratory Development, SUGEN, Inc, South San Francisco, CA 94080, USA.
Clinical Cancer Research, Jan. 2003, Vol. 9, pp. 327-337.

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis
Jenkins, D.E., Oei, Y., Hornig, Y.S., Yu, S.F., Dusich, J., Purchio, T., and Contag, P.R. Xenogen Corp., Alameda, CA 94501, USA.
Clinical and Experimental Metastasis, Jan. 2003, Vol. 20, pp. 733-744.

Noninvasive real-time imaging of apoptosis
Laxman B., Hall D.E., Bhojani M.S., Hamstra D.A., Chenevert T.L., Ross B.D., and Rehemtulla A. Center for Molecular Imaging, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Proceedings of the National Academy of Sciences of the United States of America, Dec. 2002, Vol. 99, pp. 16551-16555.

Advancing animal models of neoplasia through in vivo bioluminescence imaging
Edinger M., Cao Y.A., Hornig Y.S., Jenkins D.E., Verneris M.R., Bachmann M.H., Negrin R.S., and Contag C.H. Div. of Bone Marrow Transplantation, Dept. of Medicine, Stanford University School of Medicine, CA 94305, USA.
European Journal of Cancer, Nov. 2002, Vol. 38, pp. 2128-2136.

Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3
Scheffold C., Kornacker M., Scheffold Y.C., Contag C.H., and Negrin R.S. Div. of Bone Marrow Transplantation, Stanford University School of Medicine, Stanford, CA 94305, USA.
Cancer Research, Oct. 2002, Vol. 62, pp. 5785-5791.

Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging
Adams J.Y., Johnson M., Sato M., Berger F., Gambhir S.S., Carey M., Iruela-Arispe M.L., and Wu L. Dept. of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA 90095, USA.
Nature Medicine, Aug. 2002, Vol. 8, pp. 891-897.

Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice
Vooijs M., Jonkers J., Lyons S., and Berns A. Div. of Molecular Genetics and Centre for Biomedical Genetics, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Cancer Research, Mar. 2002, Vol. 62, pp. 1862-1867.

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy
Rehemtulla A., Hall D.E., Stegman L.D., Prasad U., Chen G., Bhojani M.S., Chenevert T.L., and Ross B.D. University of Michigan School of Medicine, USA.
Molecular Imaging, Jan.-Mar. 2002, Vol. 1, pp. 43-55.

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging
Rehemtulla A., Stegman L.D., Cardozo S.J., Gupta S., Hall D.E., Contag C.H., and Ross B.D. The Center for Molecular Imaging and the Dept. of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Neoplasia, Nov.-Dec. 2000, Vol. 2, pp. 491-495.

Use of reporter genes for optical measurements of neoplastic disease in vivo
Contag C.H., Jenkins D., Contag P.R., and Negrin R.S. Dept. of Pediatrics, Stanford University Medical Center, Stanford University, Stanford, CA 94305, USA.
Neoplasia, Jan.-Apr. 2000, Vol. 2, pp. 41-52.

Visualizing the kinetics of tumor-cell clearance in living animals
Sweeney T.J., Mailander V., Tucker A.A., Olomu A.B., Zhang W., Cao Y., Negrin R.S., and Contag C.H. Dept. of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Proceedings of the National Academy of Sciences of the United States of America, Oct. 1999, Vol. 96, pp. 12044-12049.

Noninvasive assessment of tumor cell proliferation in animal models
Edinger M., Sweeney T.J., Tucker A.A., Olomu A.B., Negrin R.S., and Contag C.H. Dept. of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Neoplasia, Oct. 1999, Vol. 1, pp. 303-310.